Advancing proteomics in nephrology: unraveling causal pathways and therapeutic targets.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37981427.
- Also identified by DOI 10.1016/j.kint.2023.10.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Proteomics has illuminated disease pathophysiology, unearthed novel biomarkers, and bolstered risk assessment strategies. In nephrology, observational analyses unveil biomarkers associated with adverse outcomes, whereas genetics offer insights into causal pathways. Mendelian randomization offers the potential to link the two, uncovering causal relationships between biomarkers and kidney function. Lanktree et al. demonstrate Mendelian randomization's utility in identifying additional proteins affecting kidney function and kidney disease progression.
Medical subject headings
- Nephrology